Palatin Technologies, Inc. (PTN)
USD 0.18
(-56.95%)
USD 0.18
(-56.95%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 163.78 Thousand USD | 0.0% |
| 2023 | 590.33 Thousand USD | -13.42% |
| 2022 | 681.8 Thousand USD | -24.29% |
| 2021 | 900.52 Thousand USD | -5.54% |
| 2020 | 953.34 Thousand USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 332.89 Thousand USD | -94.7% |
| 2017 | 6.28 Million USD | -55.78% |
| 2016 | 14.2 Million USD | 44.6% |
| 2015 | 9.82 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 19.9 Thousand USD | -52.81% |
| 2011 | 42.18 Thousand USD | 195.34% |
| 2010 | 14.28 Thousand USD | -57.93% |
| 2009 | 33.95 Thousand USD | -72.08% |
| 2008 | 121.62 Thousand USD | -55.79% |
| 2007 | 275.12 Thousand USD | 19.84% |
| 2006 | 229.58 Thousand USD | 1112.55% |
| 2005 | 18.93 Thousand USD | -37.31% |
| 2004 | 30.2 Thousand USD | -60.48% |
| 2003 | 76.43 Thousand USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 27.77 Thousand USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 2 Million USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 900 Thousand USD | -51.18% |
| 1996 | 1.84 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 262.22 Thousand USD | 0.0% |
| 2024 Q2 | 357.74 Thousand USD | 0.0% |
| 2024 Q1 | 499.57 Thousand USD | 0.0% |
| 2024 Q4 | - USD | 0.0% |
| 2023 Q2 | 480.07 Thousand USD | -18.83% |
| 2023 Q3 | 393.63 Thousand USD | -18.01% |
| 2023 FY | 590.33 Thousand USD | -13.42% |
| 2023 Q1 | 591.42 Thousand USD | -13.26% |
| 2023 Q4 | 590.33 Thousand USD | 49.97% |
| 2022 Q1 | 808.84 Thousand USD | -10.18% |
| 2022 Q2 | 920.8 Thousand USD | 13.84% |
| 2022 Q3 | 799.79 Thousand USD | -13.14% |
| 2022 FY | 681.8 Thousand USD | -24.29% |
| 2022 Q4 | 681.8 Thousand USD | -14.75% |
| 2021 Q4 | 900.52 Thousand USD | -8.69% |
| 2021 Q1 | 911.77 Thousand USD | -4.36% |
| 2021 Q2 | 855.62 Thousand USD | -6.16% |
| 2021 FY | 900.52 Thousand USD | -5.54% |
| 2021 Q3 | 986.17 Thousand USD | 15.26% |
| 2020 Q4 | 953.34 Thousand USD | 10420.28% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 953.34 Thousand USD | 0.0% |
| 2020 Q3 | 9062.00 USD | -32.81% |
| 2020 Q2 | 13.48 Thousand USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | -100.0% |
| 2019 FY | - USD | -100.0% |
| 2018 FY | 332.89 Thousand USD | -94.7% |
| 2018 Q2 | 2.32 Million USD | -46.09% |
| 2018 Q1 | 4.3 Million USD | -31.46% |
| 2018 Q4 | 332.89 Thousand USD | -74.95% |
| 2018 Q3 | 1.32 Million USD | -42.74% |
| 2017 Q2 | 10.21 Million USD | -16.1% |
| 2017 FY | 6.28 Million USD | -55.78% |
| 2017 Q3 | 8.25 Million USD | -19.2% |
| 2017 Q1 | 12.16 Million USD | -14.32% |
| 2017 Q4 | 6.28 Million USD | -23.86% |
| 2016 Q4 | 14.2 Million USD | -12.16% |
| 2016 FY | 14.2 Million USD | 44.6% |
| 2016 Q1 | 18.65 Million USD | 89.9% |
| 2016 Q2 | 17.69 Million USD | -5.14% |
| 2016 Q3 | 16.17 Million USD | -8.61% |
| 2015 Q2 | 9.78 Million USD | -0.17% |
| 2015 FY | 9.82 Million USD | 0.0% |
| 2015 Q1 | 9.8 Million USD | 0.0% |
| 2015 Q3 | 9.8 Million USD | 0.17% |
| 2015 Q4 | 9.82 Million USD | 0.17% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | 2048.00 USD | -74.77% |
| 2013 Q4 | - USD | -100.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q1 | 14.06 Thousand USD | -29.34% |
| 2013 Q2 | 8116.00 USD | -42.31% |
| 2012 Q2 | 31.26 Thousand USD | -15.0% |
| 2012 Q3 | 25.63 Thousand USD | -17.98% |
| 2012 Q4 | 19.9 Thousand USD | -22.35% |
| 2012 FY | 19.9 Thousand USD | -52.81% |
| 2012 Q1 | 36.77 Thousand USD | -12.83% |
| 2011 Q3 | 9042.00 USD | 146.85% |
| 2011 Q4 | 42.18 Thousand USD | 366.56% |
| 2011 FY | 42.18 Thousand USD | 195.34% |
| 2011 Q1 | 9042.00 USD | -36.7% |
| 2011 Q2 | 3663.00 USD | -59.49% |
| 2010 FY | 14.28 Thousand USD | -57.93% |
| 2010 Q4 | 14.28 Thousand USD | -26.34% |
| 2010 Q3 | 19.39 Thousand USD | -20.43% |
| 2010 Q2 | 24.37 Thousand USD | -16.6% |
| 2010 Q1 | 29.22 Thousand USD | -13.93% |
| 2009 Q3 | 38.56 Thousand USD | -26.75% |
| 2009 FY | 33.95 Thousand USD | -72.08% |
| 2009 Q4 | 33.95 Thousand USD | -11.95% |
| 2009 Q2 | 52.64 Thousand USD | -34.79% |
| 2009 Q1 | 80.73 Thousand USD | -33.62% |
| 2008 Q4 | 121.62 Thousand USD | -32.57% |
| 2008 Q1 | 295.58 Thousand USD | 7.44% |
| 2008 FY | 121.62 Thousand USD | -55.79% |
| 2008 Q2 | 238.35 Thousand USD | -19.36% |
| 2008 Q3 | 180.37 Thousand USD | -24.33% |
| 2007 Q1 | 272.41 Thousand USD | 18.66% |
| 2007 FY | 275.12 Thousand USD | 19.84% |
| 2007 Q3 | 335.98 Thousand USD | 17.59% |
| 2007 Q4 | 275.12 Thousand USD | -18.11% |
| 2007 Q2 | 285.71 Thousand USD | 4.88% |
| 2006 Q3 | 251.91 Thousand USD | -7.99% |
| 2006 Q4 | 229.58 Thousand USD | -8.86% |
| 2006 FY | 229.58 Thousand USD | 1112.55% |
| 2006 Q2 | 273.77 Thousand USD | 1616.05% |
| 2006 Q1 | 15.95 Thousand USD | -15.74% |
| 2005 Q4 | 18.93 Thousand USD | -9.34% |
| 2005 Q3 | 20.88 Thousand USD | -12.08% |
| 2005 Q2 | 23.75 Thousand USD | -10.56% |
| 2005 Q1 | 26.55 Thousand USD | -12.07% |
| 2005 FY | 18.93 Thousand USD | -37.31% |
| 2004 FY | 30.2 Thousand USD | -60.48% |
| 2004 Q4 | 30.2 Thousand USD | -8.1% |
| 2004 Q3 | 32.86 Thousand USD | -7.34% |
| 2004 Q1 | 38.01 Thousand USD | -50.27% |
| 2004 Q2 | 35.46 Thousand USD | -6.69% |
| 2003 Q2 | 149.85 Thousand USD | -19.64% |
| 2003 Q1 | 186.49 Thousand USD | 0.0% |
| 2003 FY | 76.43 Thousand USD | 0.0% |
| 2003 Q3 | 114.09 Thousand USD | -23.86% |
| 2003 Q4 | 76.43 Thousand USD | -33.01% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | -100.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | -100.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | 27.77 Thousand USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 FY | 27.77 Thousand USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q1 | - USD | -100.0% |
| 2000 FY | - USD | -100.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | 2 Million USD | 0.0% |
| 1999 Q4 | 2 Million USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | -50.0% |
| 1998 FY | - USD | -100.0% |
| 1998 Q1 | 700 Thousand USD | -22.22% |
| 1998 Q2 | 400 Thousand USD | -42.86% |
| 1998 Q4 | - USD | -100.0% |
| 1997 Q1 | 1.6 Million USD | -11.11% |
| 1997 Q2 | 1.3 Million USD | -18.75% |
| 1997 Q4 | 900 Thousand USD | -18.18% |
| 1997 Q3 | 1.1 Million USD | -15.38% |
| 1997 FY | 900 Thousand USD | -51.18% |
| 1996 FY | 1.84 Million USD | 0.0% |
| 1996 Q4 | 1.8 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AIM ImmunoTech Inc. | 495 Thousand USD | 66.913% |
| Ampio Pharmaceuticals, Inc. | - USD | -Infinity% |
| Armata Pharmaceuticals, Inc. | 82.3 Million USD | 99.801% |
| Actinium Pharmaceuticals, Inc. | 1.57 Million USD | 89.581% |
| Azitra, Inc. | 563.69 Thousand USD | 70.945% |
| Can-Fite BioPharma Ltd. | 13 Thousand USD | -1159.862% |
| Chromocell Therapeutics Corporation | - USD | -Infinity% |
| Calidi Biotherapeutics, Inc. | 2.06 Million USD | 92.049% |
| CEL-SCI Corporation | 11.6 Million USD | 98.588% |
| iBio, Inc. | 3.5 Million USD | 95.33% |
| Lineage Cell Therapeutics, Inc. | 2.07 Million USD | 92.088% |
| MAIA Biotechnology, Inc. | - USD | -Infinity% |
| Matinas BioPharma Holdings, Inc. | 2.89 Million USD | 94.343% |
| Navidea Biopharmaceuticals, Inc. | 1.87 Million USD | 91.25% |
| NovaBay Pharmaceuticals, Inc. | 1.1 Million USD | 85.218% |
| NanoViricides, Inc. | - USD | -Infinity% |
| Oragenics, Inc. | - USD | -Infinity% |
| BiomX Inc. | 5.4 Million USD | 96.968% |
| BiomX Inc. | 5.4 Million USD | 96.968% |
| Protalix BioTherapeutics, Inc. | 4.62 Million USD | 96.456% |
| Scorpius Holdings, Inc. | 12.61 Million USD | 98.701% |
| Theriva Biologics, Inc. | 162 Thousand USD | -1.1% |